• 1. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 2. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
• 3. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 4. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 5. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones

Recent Advances in the Study of 2-Chloro-1-(2,4,6-trihydroxyphenyl)ethanone (CAS: 110865-03-7) in Chemical Biology and Pharmaceutical Research

2-Chloro-1-(2,4,6-trihydroxyphenyl)ethanone (CAS: 110865-03-7) is a synthetic compound that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This compound, characterized by its unique trihydroxyphenyl and chloro-ethanone functional groups, has been the subject of various studies exploring its biological activities, synthetic pathways, and therapeutic potential. The following sections provide a comprehensive overview of the latest research findings related to this compound.

Recent studies have focused on the synthesis and optimization of 2-Chloro-1-(2,4,6-trihydroxyphenyl)ethanone, with researchers employing advanced techniques such as high-performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR) spectroscopy to characterize its purity and structural integrity. A study published in the Journal of Medicinal Chemistry (2023) highlighted a novel synthetic route that improves yield and reduces by-products, making the compound more accessible for further research and development.

In the realm of biological activity, 2-Chloro-1-(2,4,6-trihydroxyphenyl)ethanone has demonstrated promising antimicrobial and anti-inflammatory properties. A 2023 study in Bioorganic & Medicinal Chemistry Letters reported that the compound exhibited significant inhibitory effects against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Additionally, in vitro assays revealed its potential to modulate inflammatory pathways by inhibiting key enzymes such as cyclooxygenase-2 (COX-2).

The compound's potential as a therapeutic agent has also been explored in the context of cancer research. A recent investigation published in European Journal of Medicinal Chemistry (2024) demonstrated that 2-Chloro-1-(2,4,6-trihydroxyphenyl)ethanone induces apoptosis in certain cancer cell lines by activating the intrinsic mitochondrial pathway. These findings suggest its potential as a lead compound for the development of novel anticancer drugs.

Despite these promising results, challenges remain in the clinical translation of 2-Chloro-1-(2,4,6-trihydroxyphenyl)ethanone. Issues such as bioavailability, toxicity, and pharmacokinetics need to be addressed through further preclinical and clinical studies. Researchers are currently exploring formulation strategies, including nanoparticle-based delivery systems, to enhance the compound's therapeutic efficacy and reduce potential side effects.

In conclusion, 2-Chloro-1-(2,4,6-trihydroxyphenyl)ethanone (CAS: 110865-03-7) represents a promising candidate for various biomedical applications. Ongoing research continues to uncover its multifaceted biological activities and potential therapeutic benefits. Future studies should focus on optimizing its pharmacological properties and advancing it through the drug development pipeline.

• 29003-59-6(Ethanone,2,2-dichloro-1-(2,4-dihydroxyphenyl)-)
• 21861-21-2(Ethanone,2-chloro-1-(2,4-dihydroxy-3-methylphenyl)-)
• 145736-97-6(Ethanone,2-chloro-1-(3-ethyl-4-hydroxyphenyl)-)
• 14771-02-9(Ethanone,2-chloro-1-(2,4,5-trihydroxyphenyl)-)
• 25015-92-3(2-chloro-1-(2,4-dihydroxyphenyl)ethan-1-one)
• 393519-43-2(Ethanone,2-chloro-1-(4-hydroxy[1,1'-biphenyl]-3-yl)-)
• 115787-51-4(Benzaldehyde,5-(2-chloroacetyl)-2-hydroxy-)
• 17345-68-5(Ethanone,2-chloro-1-(2,3,4-trihydroxyphenyl)-)
• 22307-94-4(2-Chloro-1-(2-hydroxy-5-methylphenyl)ethanone)
• 244284-42-2(Ethanone,2-chloro-1-(2-hydroxy-3,5-dimethylphenyl)-)